Previous 10 | Next 10 |
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements PR Newswire The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVO...
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 PR Newswire Conference call scheduled for 9:00 AM ET ...
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution PR Newswire The collaboration w...
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide PR Newswire Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and REHOVOT, Israel ...
2024-02-06 07:41:53 ET More on Evogene Evogene Ltd. (EVGN) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Evogene Historical earnings data for Evogene Financial information for Evogene Read the full article on Seeking Alpha ...
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation PR Newswire The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human health and vitality ...
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit PR Newswire REHOVOT, Israel , Jan. 23, 2024 /PRNewswire/ -- Biomica Ltd. , a clinical-stage biopharmaceutical company developing innovative microbiome-based therap...
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug PR Newswire The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica's microbiome-based immuno-oncology drug, BMC128 RE...
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024 PR Newswire REHOVOT, Israel , Dec. 21, 2023 /PRNewswire/ -- Biomica Ltd. , a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and ...
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation PR Newswire Mr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company's significant operational expansion REHOVOT, Israel , Dec. 19, 2023 /PRNewswire/ -- ...
News, Short Squeeze, Breakout and More Instantly...
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants PR Newswire More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and ...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat PR Newswire Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 ...
2024-06-27 08:15:04 ET Alliance Global Partners analyst issues BUY recommendation for EVGN on June 27, 2024 07:06AM ET. The previous analyst recommendation was Buy. EVGN was trading at $0.6436 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...